Disclaimer: This page is intended for healthcare professionals only.
Meet Anna:
‡ She wants something to treat her “urinary tract infection” (UTI) and the pain and burning she’s experiencing.
-
34-year-old female
-
Office Manager
-
Generally healthy
-
No allergies
-
Combined oral contraceptive (COC) x 11 years and occasional use of ibuprofen for tension headaches
A SCHOLAR HAMS assessment revealed the following:
SCHOLAR
Symptoms
- Dysuria
- Frequency
- Urgency
- No vaginal discharge
Characteristics
- No nausea
- Vomiting
- Chills
- Fever
- Malaise
- Flank/Back pain
History
- Last UTI more than 12 months ago
- Treatment prescribed by pharmacist resolved symptoms: Nitrofurantoin 100mg PO† BID‡ x 5 days
Onset
- Began 2 days ago
Location
- Suprapubic area
Aggravating factors
- Urination increases burning pain
Remitting Factors
- Heat to the abdomen
HAMS
Health Status
- Occasional tension headaches
- No chronic health conditions
Allergies/Intolerances
- No known allergies
Medication History
- Ibuprofen for headache
- COC for birth control
Social history
- Balanced diet
- Walks/runs 3–4 times a week
- Does not smoke
- Drinks wine on weekends
- Sexually active (in a relationship)
Anna’s pharmacist recommended Cystoplus® to manage symptoms and an antibiotic for overall treatment, providing holistic and patient-centric care. The pharmacist also counselled her on proper use of Cystoplus® and helped manage her treatment expectations.
- †Although Cystoplus® Sodium Citrate Powder is not contraindicated for use with antibiotics, unknown interactions may exist. Patients should always inform their primary care provider if they are taking any other medication. With its alkalizing effect on urine, sodium citrate can affect the excretion of certain antibiotics and alter their pharmacokinetic profile. Health care professionals must use clinical discretion.
- ‡Based on a real-life case.
Disclaimers
- Always direct the patient to read the label.
- For more information: See Warnings, Cautions, and Directions of Use at https://health-products.canada.ca/lnhpd-bdpsnh/info?licence=80034529 for information to assist in benefit-risk assessment. The terms of Market Authorization are also available upon request by calling 1-888-550-6060.